^“The RNA component of human telomerase”. Science269 (5228): 1236–41. (September 1995). Bibcode: 1995Sci...269.1236F. doi:10.1126/science.7544491. PMID (7544491).
^“Cell cycle-dependent recruitment of telomerase RNA and Cajal bodies to human telomeres”. Molecular Biology of the Cell17 (2): 944–54. (February 2006). doi:10.1091/mbc.E05-09-0904. PMC 1356602. PMID (16319170). https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1356602/.
^“Telomerase RNAs of different ciliates have a common secondary structure and a permuted template”. Genes & Development8 (16): 1984–98. (August 1994). doi:10.1101/gad.8.16.1984. PMID (7958872).
^“Structure and function of telomerase RNA”. Current Opinion in Structural Biology16 (3): 307–18. (June 2006). doi:10.1016/j.sbi.2006.05.005. PMID (16713250).
^“Comparative functional study of the viral telomerase RNA based on natural mutations”. The Journal of Biological Chemistry280 (25): 23502–15. (June 2005). doi:10.1074/jbc.M501163200. PMID (15811851).
^“Loss of Human TGS1 Hypermethylase Promotes Increased Telomerase RNA and Telomere Elongation”. Cell Reports30 (5): 1358–1372.e5. (February 2020). doi:10.1016/j.celrep.2020.01.004. PMC 7156301. PMID (32023455). https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7156301/.
^Rich, Robert R. (2018-01-13). Clinical immunology : principles and practice (Fifth ed.). [St. Louis, Mo.]. ISBN (978-0-7020-7039-6). OCLC 1023865227
^Swigris, Jeffrey J; Brown, Kevin K (2018-07-25). Idiopathic pulmonary fibrosis. St. Louis. ISBN (978-0-323-54432-0). OCLC 1053744041
^“Human papillomavirus and human telomerase RNA component gene in cervical cancer progression”. Scientific Reports9 (1): 15926. (November 2019). Bibcode: 2019NatSR...915926L. doi:10.1038/s41598-019-52195-5. PMC 6828729. PMID (31685833). https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6828729/.
^“Overexpression of cellular telomerase RNA enhances virus-induced cancer formation”. Oncogene38 (10): 1778–1786. (March 2019). doi:10.1038/s41388-018-0544-1. PMID (30846849).
^“Demonstration of constant upregulation of the telomerase RNA component in human gastric carcinomas using in situ hybridization”. The Journal of Pathology185 (2): 139–44. (June 1998). doi:10.1002/(SICI)1096-9896(199806)185:2<139::AID-PATH79>3.0.CO;2-L. PMID (9713339).
^“LncRNA TERC alleviates the progression of osteoporosis by absorbing miRNA-217 to upregulate RUNX2”. European Review for Medical and Pharmacological Sciences24 (2): 526–534. (January 2020). doi:10.26355/eurrev_202001_20029. PMID (32016954).
^“Telomere-associated genes and telomeric lncRNAs are biomarker candidates in lung squamous cell carcinoma (LUSC)”. Experimental and Molecular Pathology112: 104354. (February 2020). doi:10.1016/j.yexmp.2019.104354. PMID (31837325).
関連文献
“For better or worse? Telomerase inhibition and cancer”. Cell98 (3): 273–5. (August 1999). doi:10.1016/S0092-8674(00)81955-8. PMID (10458601).
“Dyskeratosis congenita: molecular insights into telomerase function, ageing and cancer”. Expert Reviews in Molecular Medicine6 (26): 1–23. (December 2004). doi:10.1017/S1462399404008671. PMID (15613268).
“Mutations of telomerase complex genes linked to bone marrow failures”. Journal of Nippon Medical School = Nippon Ika Daigaku Zasshi74 (3): 202–9. (June 2007). doi:10.1272/jnms.74.202. PMID (17625368).
“Mapping of the gene for the mouse telomerase RNA component, Terc, to chromosome 3 by fluorescence in situ hybridization and mouse chromosome painting”. Genomics41 (2): 293–4. (April 1997). doi:10.1006/geno.1997.4621. PMID (9143511).
“Cloning and characterization of human and mouse telomerase RNA gene promoter sequences”. Oncogene16 (10): 1345–50. (March 1998). doi:10.1038/sj.onc.1201892. PMID (9546436).
“A telomerase component is defective in the human disease dyskeratosis congenita”. Nature402 (6761): 551–5. (December 1999). Bibcode: 1999Natur.402..551M. doi:10.1038/990141. PMID (10591218).
“Telomere dysfunction impairs DNA repair and enhances sensitivity to ionizing radiation”. Nature Genetics26 (1): 85–8. (September 2000). doi:10.1038/79232. PMID (10973255).
“Human telomerase activation requires two independent interactions between telomerase RNA and telomerase reverse transcriptase”. Molecular Cell6 (2): 361–71. (August 2000). doi:10.1016/S1097-2765(00)00036-8. PMID (10983983).
“SNO is a probable target for gene amplification at 3q26 in squamous-cell carcinomas of the esophagus”. Biochemical and Biophysical Research Communications286 (3): 559–65. (August 2001). doi:10.1006/bbrc.2001.5428. PMID (11511096).
“The RNA component of telomerase is mutated in autosomal dominant dyskeratosis congenita”. Nature413 (6854): 432–5. (September 2001). Bibcode: 2001Natur.413..432V. doi:10.1038/35096585. PMID (11574891).
“Effects of cisplatin on telomerase activity and telomere length in BEL-7404 human hepatoma cells”. Cell Research12 (1): 55–62. (March 2002). doi:10.1038/sj.cr.7290110. PMID (11942411).
“Nucleolar localization of hTERT protein is associated with telomerase function”. Experimental Cell Research277 (2): 201–9. (July 2002). doi:10.1006/excr.2002.5541. PMID (12083802).
“Differential regulation of telomerase activity by six telomerase subunits”. European Journal of Biochemistry269 (14): 3442–50. (July 2002). doi:10.1046/j.1432-1033.2002.03025.x. PMID (12135483).
“Minimum length requirement of the alignment domain of human telomerase RNA to sustain catalytic activity in vitro”. Nucleic Acids Research30 (20): 4470–80. (October 2002). doi:10.1093/nar/gkf575. PMC 137139. PMID (12384594). https://www.ncbi.nlm.nih.gov/pmc/articles/PMC137139/.
“p53 null mutations are associated with a telomerase negative phenotype in ovarian carcinoma”. Cancer Biology & Therapy1 (5): 511–7. (2003). doi:10.4161/cbt.1.5.167. PMID (12496479).